FDA Senior Staff Has Final Say Over Disputes In Enzi/Kennedy Bill
This article was originally published in The Tan Sheet
Senior FDA officials will have final say over drug safety disputes under proposed legislation from Sens. Michael Enzi (R-Wyo.) and Edward Kennedy (D-Mass.)
You may also be interested in...
FDA's description of its plan to improve oversight of drug safety acknowledges the agency's efforts are part of an ongoing process - but not necessarily one needing outside involvement
Pending legislation on adverse event reporting does not go far enough in expanding regulatory oversight of dietary supplements, the American College of Cardiology president told a Senate committee Nov. 16
A Government Accountability Office report on drug safety recommends giving FDA the power to mandate postmarketing drug studies